Yüklüyor......
A Phase II Trial of Valproic Acid in Patients with Advanced, Radioiodine-Resistant Thyroid Cancers of Follicular Cell Origin
OBJECTIVE: Valproic acid (VA) is a histone deacetylase (HDAC) inhibitor that has antiproliferative effects on several types of cancer, including thyroid cancer. In addition, VA has been reported to upregulate the sodium-iodine symporter in thyroid cancer cells and increases radioiodine uptake in pre...
Kaydedildi:
| Yayımlandı: | Clin Endocrinol (Oxf) |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581405/ https://ncbi.nlm.nih.gov/pubmed/27392538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13154 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|